DETERMINATION OF NORFLOXACIN, A NEW NALIDIXIC ACID ANALOG, IN HUMAN SERUM AND URINE BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHYBOPPANA VK; SWANSON BN.1982; ANTIMICROB. AGENTS CHEMOTHER.; ISSN 0066-4804; USA; DA. 1982; VOL. 21; NO 5; PP. 808-810; BIBL. 6 REF.Article

EFFECTS OF CAPTOPRIL, DIURETIC, AND THEIR COMBINATION IN LOW-RENIN ESSENTIAL HYPERTENSIONFERGUSON RK; VLASSES PH; SWANSON BN et al.1980; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1980; VOL. 27; NO 25-26; PP. 2519-2522; BIBL. 17 REF.Article

PHARMACOKINETICS OF N-(4-HYDROXYPHENYL)-ALL-TRANS-RETINAMIDE IN RATSSWANSON BN; ZAHAREVITZ DW; SPORN MB et al.1980; DRUG METABOL. DISPOSIT.; USA; DA. 1980; VOL. 8; NO 3; PP. 168-172; BIBL. 30 REF.Article

NORFLOXACIN DISPOSITION AFTER SEQUENTIALLY INCREASING ORAL DOSESSWANSON BN; BOPPANA VK; VLASSES PH et al.1983; ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; ISSN 0066-4804; USA; DA. 1983; VOL. 23; NO 2; PP. 284-288; BIBL. 7 REF.Article

PERIPHERAL NEUROPATHY AFTER CONCOMITANT ADMINISTRATION OF DIMETHYL SULFOXIDE AND SULINDACSWANSON BN; FERGUSON RK; RASKIN NH et al.1983; ARTHRITIS AND RHEUMATISM; ISSN 0004-3591; USA; DA. 1983; VOL. 26; NO 6; PP. 791-793; BIBL. 11 REF.Article

METABOLISM OF 13-CIS-RETINOIC ACID: IDENTIFICATION OF 13-CIS-RETINOYL- AND 13-CIS-4-OXORETINOYL-BETA -GLUCURONIDES IN THE BILE OF VITAMIN-4-NORMAL RATSFROLIK CA; SWANSON BN; DART LL et al.1981; ARCH. BIOCHEM. BIOPHYS.; ISSN 0003-9861; USA; DA. 1981; VOL. 208; NO 2; PP. 344-352; BIBL. 37 REF.Article

BIOTRANSFORMATION AND BIOLOGICAL ACTIVITY OF N-(4-HYDROXYPHENYL) RETINAMIDE DERIVATIVES IN RODENTSSWANSON BN; NEWTON DL; ROLLER PP et al.1981; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1981; VOL. 219; NO 3; PP. 632-637; BIBL. 26 REF.Article

ELEVATION IN ANALGETIC EFFECT AND PLASMA LEVELS OF MORPHINE BY DESIPRAMINE IN RATSGOLDSTEIN FJ; PARVIZ MOJAVERIAN; OSSIPOV MH et al.1982; PAIN (AMST.); ISSN 0304-3959; NLD; DA. 1982; VOL. 14; NO 3; PP. 279-282; BIBL. 13 REF.Article

EXCRETION OF VALPROIC ACID INTO SEMEN OF RABBITS AND MANSWANSON BN; HARLAND RC; DICKINSON RG et al.1978; EPILEPSIA; USA; DA. 1978; VOL. 19; NO 6; PP. 541-546; ABS. FRE/SPA/GER; BIBL. 17 REF.Article

THE METABOLISM OF FLOCTAFENIN IN MAN AND RODENTSLYNN RK; HOLM R; SWANSON BN et al.1979; J. CLIN. PHARMACOL.; USA; DA. 1979; VOL. 19; NO 1; PP. 20-30; BIBL. 12 REF.Article

EXCRETION OF PHENYTOIN INTO SEMEN OF RABBITS AND MAN. COMPARISON WITH PLASMA LEVELS.SWANSON BN; LEGER RM; GORDON WP et al.1978; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1978; VOL. 6; NO 1; PP. 70-74; BIBL. 32 REF.Article

INFLUENCE OF CIMETIDINE ON THE PHARMACOKINETICS OF MORPHINE IN RATSMOJAVERIAN P; SWANSON BN; DUDASH ML et al.1982; RES. COMMUN. SUBST. ABUSE; ISSN 504122; USA; DA. 1982; VOL. 3; NO 1; PP. 1-10; BIBL. 2 P.Article

LOW-DOSE CAPTOPRILVLASSES PH; ROTMENSCH HH; SWANSON BN et al.1982; ARCH. INTERN. MED. (1960); ISSN 0003-9926; USA; DA. 1982; VOL. 142; NO 6; PP. 1098-1101; BIBL. 28 REF.Article

SULINDAC DISPOSITION WHEN GIVEN ONCE AND TWICE DAILYSWANSON BN; BOPPANA VK; VLASSES PH et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 3; PP. 397-403; BIBL. 19 REF.Article

ANGIOTENSIN CONVERTING ENZYME ACTIVITY IN HUMAN SERUM RELATIONSHIP TO ENZYME INHIBITOR IN VIVO AND IN VITROSWANSON BN; HICHENS M; PARVIZ MOJAVERIAN et al.1981; RES. COMMUN. CHEM. PATHOL. PHARMACOL.; ISSN 0034-5164; USA; DA. 1981; VOL. 33; NO 3; PP. 525-536; BIBL. 3 P.Article